Pharma Foods:With the ability to self-monitor symptoms and disease outcomes and with the increased focus on pharma foods to prevent disease and augment health through nutrition, the industry needs to re-assess its strategy of drug design and development in isolation. Clearly the time has come that patient self-management and wellness preferences be considered as part of new biopharmaceutical drug program development. The fact that co-innovation programs are underway between pharmaceutical organizations and food companies to leverage the movement to prevent disease through a more holistic approach including nutrition, is noteworthy. What must be ensured is the early and clear voice for the patient during the design stage (Allarakhia, 2015).
Read More...